Home \ Neurology \ Post-Stroke Rehabilitation: Evidence-Based Support for Mexidol®

Post-stroke rehabilitation: evidence base for the drug Mexidol®

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:

00:00
Rehabilitation methods after stroke
02:55
Basic principles of rehabilitation after stroke
06:40
The role of the attending physician in the rehabilitation of a patient with a stroke
08:50
The role of the therapist in the rehabilitation of patients after stroke
10:23
The main syndromes of patients after stroke
15:00
Screening scales to assess the condition of patients
16:48
Medication rehabilitation and the choice of drugs
18:20
Restoration of neuroplasticity
22:00
The evidence base of Mexidol® after a stroke
25:10
Stroke and rehabilitation prevention: opportunities and tasks

Ostroumova Olga Dmitrievna – Doctor of Medical Sciences, Professor, Head. Department of Therapy and Polymorbid Pathology named after. Academician M.S. Vovsi FSBEI DPO RMANPE Ministry of Health of Russia

Vitaly Vladimirovich Kovalchuk – Doctor of Medical Sciences, Professor, Chairman of the Society of Rehabilitation Specialists of St. Petersburg, Head of the Department of Neurological Rehabilitation of the St. Petersburg State Budgetary Healthcare Institution “City Hospital No. 38 named after N.A. Semashko”

Announcement:

It was previously believed that rehabilitation after a stroke should be delayed for several days or weeks to avoid harming the patient. However, recent research has shown that rehabilitation must begin within the first few hours to avoid severe complications such as neglect syndrome, muscle spasticity, pain syndromes, and psychoemotional and cognitive impairment. Rehabilitation is based on two principles: a multidisciplinary approach to the consequences of a stroke and timely medication support to promote adequate interneuronal connections— one of the key criteria for neuroplasticity.

All videos Next video

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:

00:00
Rehabilitation methods after stroke
02:55
Basic principles of rehabilitation after stroke
06:40
The role of the attending physician in the rehabilitation of a patient with a stroke
08:50
The role of the therapist in the rehabilitation of patients after stroke
10:23
The main syndromes of patients after stroke
15:00
Screening scales to assess the condition of patients
16:48
Medication rehabilitation and the choice of drugs
18:20
Restoration of neuroplasticity
22:00
The evidence base of Mexidol® after a stroke
25:10
Stroke and rehabilitation prevention: opportunities and tasks

Block of articles on this topic

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in acute and early restorations. Periods

Authors:
L.V. STAKHOVSKAYA¹, N.A. SHAMALOV¹, D.R. KHASANOVA², E.V. MELNIKOVA³, A.S. AGAFINA⁴, K.V. GOLIKOV⁵, E.I. BOGDANOV⁶, A.A. YAKUPOVA⁶, L.V. ROSHKOVSKA⁷, L.V. LUKINYKH⁸, T.M. LOKSHTANOVA⁹, I.E. Poverennova¹⁰, L.A. SCHEPANKEVICH¹¹

¹Research Institute of Cerebrovascular Pathology and Stroke, Pirogov Russian National Research Medical University, Moscow, Russia;
²Interregional Clinical and Diagnostic Center, Kazan, Russia;
³St. Petersburg City Hospital No. 26, St. Petersburg, Russia;
⁴St. Petersburg City Hospital No. 40 of the Kurortny Administrative District, St. Petersburg, Russia;
⁵St. Petersburg City Multidisciplinary Hospital No. 2, St. Petersburg, Russia;
⁶Kazan State Medical University, Kazan, Russia;
⁷St. Petersburg Nikolaevskaya Hospital, St. Petersburg, Russia;
⁸Vsevolozhsk Clinical Interdistrict Hospital, Leningrad Region, Russia.
⁹MUBZ City Clinical Hospital No. 1 named after N.I. Pirogov, Samara, Russia;
¹⁰State Budgetary Healthcare Institution Samara Regional Clinical Hospital named after V.D. Seredavin, Samara, Russia;
¹¹Federal State Budgetary Scientific Institution Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia.

The effect of therapy with the drug Mexol on the regression of neurological deficiency and a functional outcome in patients with ischemic stroke: a systematic review and meta analysis

Authors:
I.A. VOZNYUK^1,2, S.V. KOLOMETSEV^2,3, E.M. MOROZOVA¹

Features of the treatment and rehabilitation of patients who suffered Covid-19 with ischemic stroke

Authors:
G.S. RAHIMBAEVA, S.R. GAZIEVA, M.K. ATANIYAZOV, F.Kh. MURATOV, D.S. TOLIPOV, U.D. SHODIEV

Tashkent Medical Academy, Tashkent, Republic of Uzbekistan

Review of clinical recommendations for the treatment and prevention of ischemic stroke

Author:
A.I. FEDIN, K.R. BADALYAN

FSBEI in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

The effectiveness of the use of ethylmethylhydroxypyridine of succinate in the restoration treatment of patients who have undergone ischemic stroke

Authors:
M.V. ZHURAVLEVA^1,2, A.B. PROKOFIEV^1,2, V.V. ARKHIPOV¹, S.Yu. SEREBROVA^1,2, G.I. GORODETSKAYA^1,2, O.A. DEMIDOVA¹

¹Federal State Budgetary Institution "Scientific Center for Expertise of Medical Products" of the Ministry of Health of the Russian Federation, Moscow, Russia;
²Federal State Autonomous Educational Institution of Higher Education "I.M. Sechenov First Moscow State Medical University" of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com